Pembrolizumab
Day 2 ESMO 2021 Roundup: New Paradigms for Long-Term Cancer Care and Immunotherapies for High Risk Metastatic Cancers
2021-09-19
First Non-Gene Edited CAR-T to Partner with Merck’s Blockbuster Against Colorectal Cancer
2020-10-01
ASCO 2020: Keytruda Shines as New Quality of Care in Treating metastatic Colorectal Cancer
2020-06-03
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115